{"id":100264,"date":"2024-01-24T18:39:36","date_gmt":"2024-01-24T13:09:36","guid":{"rendered":"http:\/\/finservwealth.com\/five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch\/"},"modified":"2024-01-24T18:39:36","modified_gmt":"2024-01-24T13:09:36","slug":"five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch\/","title":{"rendered":"Five IPOs including JNK India, Entero Healthcare, Exicom Tele-Systems get SEBI approval for IPO launch"},"content":{"rendered":"<p> Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19<\/p><div id=\"finse-3354879259\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch_17414241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19 Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch_17414241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch_17414241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19 Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/five-ipos-including-jnk-india-entero-healthcare-exicom-tele-systems-get-sebi-approval-for-ipo-launch_17414241.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Entero Healthcare Solutions IPO has received observation letter from the market regulator on January 16, while the SEBI issued the said letter to Exicom Tele-Systems IPO, and Stallion India Fluorochemicals IPO on January 19<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-100264","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/s\/stocks_sensex_nifty_stock-2_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/100264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=100264"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/100264\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=100264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=100264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=100264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}